Neurodegenerative ailments feature defects in equally NRF2-mediated antioxidant defenses and mitochondrial electron transport chain activity, which can be ameliorated through glutathione repletion.The profitable software of intranasal glutathione in PD, evidenced by improvements in oxidative strain markers and symptom management, provides a robust